Quell Tx

Details

  • Unternehmenstyp
    Globaler Konzern
About Quell Tx

Quell Tx is a biopharmaceutical company focused on developing innovative therapies for autoimmune and inflammatory diseases, as well as organ transplantation. Founded in March 2019, the company collaborates with leading immunological experts and is led by Iain McGill, who has extensive experience in immunology. Quell Tx aims to create transformational therapies based on modular engineered Tregs.

Career Opportunities

Quell Tx offers a dynamic working environment that fosters professional growth and innovation. Employees are encouraged to contribute to groundbreaking research and development in the biopharmaceutical field.

  • Collaborative work culture
  • Opportunities for professional development
  • Engagement in cutting-edge research
>